E-LIB Suche - Ergebnisse für: Edeline, J

1

Drug–drug interactions with proton pump inhibitors in cance..:

Raoul, J.L. ; Moreau-Bachelard, C. ; Gilabert, M...
ESMO Open. 8 (2023) 1 - p. 100880 , 2023

Link: https://doi.org/10.1016/..

2

How I treat biliary tract cancer:

Lamarca, A. ; Edeline, J. ; Goyal, L.
ESMO Open. 7 (2022) 1 - p. 100378 , 2022

Link: https://doi.org/10.1016/..

3

Abstract No. 117 A phase 3, double-blind, randomized study ..:

Sangro, B. ; Harding, J. ; Johnson, M....
Journal of Vascular and Interventional Radiology. 32 (2021) 5 - p. S52-S53 , 2021

Link: https://doi.org/10.1016/..

4

Severe accident studies on the efficiency of mitigation dev..:

Bachrata, A. ; Bertrand, F. ; Marie, N....
Nuclear Engineering and Design. 373 (2021) - p. 111037 , 2021

Link: https://doi.org/10.1016/..

5

Trifluridine/tipiracil in combination with oxaliplatin and ..:

Bordonaro, R. ; Calvo, A. ; Auriemma, A....
ESMO Open. 6 (2021) 5 - p. 100270 , 2021

Link: https://doi.org/10.1016/..

6

PO-1263 Exclusive radiotherapy in early stage anal cancer -..:

Briens, A. ; Neuzillet, C. ; Huguet, F....
Radiotherapy and Oncology. 161 (2021) - p. S1042-S1043 , 2021

Link: https://doi.org/10.1016/..

7

Impact pronostique de l'hypermétabolisme thyroïdien en TEP ..:

Frelau, A. ; Edeline, J. ; Palard Novello, X....
Médecine Nucléaire. 44 (2020) 2 - p. 94 , 2020

Link: https://doi.org/10.1016/..

8

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F. ; Floquet, A. ; Hardy-Bessard, A.C....
Gynecologic Oncology. 158 (2020) 3 - p. 666-672 , 2020

Link: https://doi.org/10.1016/..

9

Metastatic clear-cell renal cell carcinoma: Computed tomogr..:

Khene, Z-E. ; Kokorian, R. ; Peyronnet, B....
European Urology Open Science. 19 (2020) - p. e1103-e1104 , 2020

Link: https://doi.org/10.1016/..

10

Impact pronostique des dysthyroïdies sur la survie sans pro..:

Frelau, A. ; Jali, E. ; Campillo-Gimenez, B....
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A310 , 2020

Link: https://doi.org/10.1016/..

11

Impact de la dosimétrie personnalisée sur la réponse tumora..:

Garin, E. ; Tselikas, L. ; Guiu, B....
Médecine Nucléaire. 43 (2019) 2 - p. 180 , 2019

Link: https://doi.org/10.1016/..

12

MON-PO377: Are Body Composition Parameters Associated with ..:

Som, M. ; Brac de la Perriere, C. ; Viaud, J....
Clinical Nutrition. 38 (2019) - p. S198 , 2019

Link: https://doi.org/10.1016/..

13

Les paramètres de composition corporelle (CC) sont-ils asso..:

Som, M. ; Brac de la Perrière, C. ; Viaud, J....
Nutrition Clinique et Métabolisme. 33 (2019) 1 - p. 76 , 2019

Link: https://doi.org/10.1016/..

14

Results of the Phase II randomized French trial PRODIGE 21 ..:

Blanc, J.-F. ; Khemissa, F. ; Bronowicki, J.-P....
Journal of Hepatology. 68 (2018) - p. S195 , 2018

Link: https://doi.org/10.1016/..

15

Transarterial Radioembolization (TARE) Agents beyond 90Y-Mi..:

Bouvry, C. ; Palard, X. ; Edeline, J....
BioMed Research International. 2018 (2018) - p. 1-14 , 2018

Link: https://doi.org/10.1155/..